Loading
Latest filing published 04 Apr 2017 for Protea Biosciences Group, Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Steve Antoline is a declared insider of Protea Biosciences Group, Inc., with filings sourced from SEC (Form 4). In total, 21 filings cover trades dated from 30 September 2011 to 24 March 2017.
The open-market record is one-sided, with 14 purchases worth €2.4M and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant.
A typical purchase (the median) is worth €81k.
The latest filing, published on 4 April 2017, reports a transaction in Protea Biosciences Group, Inc. The clock since the last published purchase (13 February 2014) now reads 4,635 days. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
21 of 21 declarations